Ledger.Open graph →
SEC Form D · Amendment · filed August 6, 2019

Pharmazz, Inc

Offering
$724K
Sold
$724K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILLOWBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Frederic Mayerson · Cincinnati, OHExec · DirectorTadmor Shalon · Sonoma, CAExecMetaProp Holdings LLC · New York, NYExecAaron Block · New York, NYDirectorGeoff L. Tabachnick · New York, NYExecKorey Korfiatis · Wenatchee, WAExec · DirectorThomas L. Mcdougal · DALLAS, TXExecEric L. Langford · DALLAS, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗